Megakaryocyte Disorders and Thrombocytosis

Reactive versus clonal thrombocytosis differential

Written by: Saygı Hospital Health Guide Editorial Board

Last updated: June 20, 2026

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Megakaryocyte Disorders and Thrombocytosis?

Megakaryocytes are the largest bone marrow cells and they generate circulating platelets. Disorders of these cells produce abnormalities in platelet number such as thrombocytosis or thrombocytopenia and in platelet function with implications for both bleeding and clotting.

When platelets exceed four hundred fifty thousand the key division is between reactive and clonal causes. Reactive thrombocytosis from infection, inflammation, iron deficiency, post splenectomy state and surgery accounts for most cases and rarely raises thrombosis risk on its own.

Clonal thrombocytosis arises in myeloproliferative neoplasms including essential thrombocythemia, polycythemia vera, primary myelofibrosis and chronic myeloid leukemia. JAK2 V617F, CALR and MPL mutations confirm clonality and IPSET or revised IPSET thrombosis scores guide risk stratification.

Symptoms

Frequently incidental finding on counts

Erythromelalgia burning red extremities

Microvascular headache or visual aura

Thrombotic events including atypical sites

Acquired von Willebrand bleeding extreme counts

Risk Factors

JAK2 CALR or MPL driver mutation

Iron deficiency for reactive form

Chronic inflammatory disease

Post splenectomy state

Older age and cardiovascular comorbidity

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

When platelet count exceeds four hundred fifty thousand
When reactive causes are excluded
When erythromelalgia or microvascular symptoms appear
After any thrombotic event

Treatment Methods

Treat underlying cause for reactive thrombocytosis

Low dose aspirin in low risk essential thrombocythemia

Hydroxyurea plus aspirin for high risk

Anagrelide on hydroxyurea intolerance

Ruxolitinib in selected JAK2 mutant cases

Plateletpheresis for emergency complications

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book Appointment Contact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.